• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Res . Cough and sputum in long COVID are associated with severe acute COVID-19: a Japanese cohort study

tetano

Editor, Senior Moderator
Respir Res


. 2023 Nov 14;24(1):283.
doi: 10.1186/s12931-023-02591-3. Cough and sputum in long COVID are associated with severe acute COVID-19: a Japanese cohort study

Mayuko Watase[SUP] 1 2 [/SUP], Jun Miyata[SUP] 3 [/SUP], Hideki Terai[SUP] 4 5 [/SUP], Keeya Sunata[SUP] 1 [/SUP], Emiko Matsuyama[SUP] 1 [/SUP], Takanori Asakura[SUP] 1 [/SUP], Ho Namkoong[SUP] 6 [/SUP], Katsunori Masaki[SUP] 1 [/SUP], Kazuma Yagi[SUP] 1 [/SUP], Keiko Ohgino[SUP] 1 [/SUP], Shotaro Chubachi[SUP] 1 [/SUP], Ichiro Kawada[SUP] 1 7 [/SUP], Takao Mochimaru[SUP] 2 [/SUP], Ryosuke Satomi[SUP] 2 [/SUP], Yoshitaka Oyamada[SUP] 2 [/SUP], Keigo Kobayashi[SUP] 8 [/SUP], Toshiyuki Hirano[SUP] 8 [/SUP], Takashi Inoue[SUP] 8 [/SUP], Ho Lee[SUP] 9 [/SUP], Kai Sugihara[SUP] 9 [/SUP], Nao Omori[SUP] 9 [/SUP], Koichi Sayama[SUP] 9 [/SUP], Shuko Mashimo[SUP] 10 [/SUP], Yasushi Makino[SUP] 10 [/SUP], Tatsuya Kaido[SUP] 10 [/SUP], Makoto Ishii[SUP] 11 [/SUP], Koichi Fukunaga[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Multiple prolonged symptoms are observed in patients who recover from acute coronavirus disease 2019 (COVID-19), defined as long COVID. Cough and sputum are presented by patients with long COVID during the acute and post-acute phases. This study aimed to identify specific risk factors for cough and sputum in patients with long COVID.
Methods: Hospitalized patients with COVID-19 aged 18 years were enrolled in a multicenter cohort study at 26 medical institutions. Clinical data during hospitalization and patient-reported outcomes after discharge were collected from medical records, paper-based questionnaires, and smartphone apps.
Results: At the 3-, 6-, and 12-month follow-ups, there were no differences in the incidence rates of wet and dry coughs. In contrast, the proportion of patients presenting sputum without coughing increased over time compared to those with sputum and coughing. Univariate analyses of cough and sputum at all follow-up visits identified intermittent mandatory ventilation (IMV), smoking, and older age as risk factors for prolonged symptoms. At the 12-month follow-up, persistent cough and sputum were associated with the characteristics of severe COVID-19 based on imaging findings, renal and liver dysfunction, pulmonary thromboembolism, and higher serum levels of LDH, KL-6, and HbA1C. The Kaplan-Meier curves showed that the severity of acute COVID-19 infection was correlated with prolonged cough and sputum production. Multivariable logistic regression analysis showed that IMV ventilator management were independent risk factors for prolonged cough and sputum at 12 months.
Conclusions: In a Japanese population with long COVID, prolonged cough and sputum production were closely associated with severe COVID-19. These findings emphasize that a preventive approach including appropriate vaccination and contact precaution and further development of therapeutic drugs for COVID-19 are highly recommended for patients with risk factors for severe infection to avoid persistent respiratory symptoms.

Keywords: Cough; Japanese cohort study; Long COVID; Severity; Sputum.

 
Back
Top Bottom